Skip to main content
. 2019 Aug 6;37(34):3243–3255. doi: 10.1200/JCO.19.00919

FIG 3.

FIG 3.

(A) Event-free survival (EFS) and overall survival (OS) for evaluable infants with stage 4 disease younger than 365 days of age (n = 125). (B) EFS for evaluable infants with stage 4 disease younger than 365 days of age according to tumor biology (n = 108; P = .02). (C) OS for evaluable infants with stage 4 disease younger than 365 days of age according to tumor biology (n = 108; P = .08). Favorable biology constituted hyperdiploid tumors with favorable histology and normal 1p and 11q alleles. Unfavorable biology tumors had at least one unfavorable feature (diploidy, unfavorable histology, 1p loss of heterozygosity, or 11q loss of heterozygosity).